Slrx stock

Salarius Pharmaceuticals, Inc. (SLRX) Stock Price, News …

Market Cap, 4.944M ; Beta (5Y Monthly), 1.15 ; PE Ratio (TTM), N/A ; EPS (TTM), -0.4970 ; Earnings Date, Mar 08, 2023 – Mar 13, 2023.

Salarius Pharmaceuticals Inc. Stock Quote (U.S. – SLRX

SLRX Stock Price | Salarius Pharmaceuticals Inc. Stock Quote (U.S.: Nasdaq) | MarketWatch

SLRX | Complete Salarius Pharmaceuticals Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.

$SLRX – Salarius Pharmaceuticals Inc Stock – StockTwits

Salarius Pharmaceuticals Inc Stock – SLRX Share Price Today, News and Discussion

for 1 dag siden — SLRX Stock Price – Salarius Pharmaceuticals, Inc. is a clinical-stage oncology company. The firm focuses on the development of Salarius’ …

SLRX Stock Price – Salarius Pharmaceuticals, Inc. is a clinical-stage oncology company. The firm focuses on the development of Salarius’ clinical pipeline, which targets rare, orphan cancers and cancers with a high unmet

Salarius Pharmaceuticals Inc SLRX:NASDAQ – CNBC

Salarius Pharmaceuticals Inc SLRX:NASDAQ ; Last | 02/10/23 EST. 2.03 quote price arrow up +0.05 (+2.53%) ; Volume. 9,240 ; 52 week range. 1.07 – 13.46 …

Salarius Pharmaceuticals, Inc. Common Stock (SLRX) – Nasdaq

Salarius Pharmaceuticals, Inc. Common Stock (SLRX) Stock Price, Quote, News & History | Nasdaq

Today’s High/Low, $2.10/$1.952 ; Share Volume, 9,717 ; Average Volume, 223,019 ; Previous Close, $1.98.

Salarius Pharmaceuticals, Inc. Common Stock (SLRX) Stock Quotes – Nasdaq offers stock quotes & market activity data for US and global markets.

Salarius Pharmaceuticals Inc. Stock Overview (U.S. – SLRX

SLRX | Salarius Pharmaceuticals Inc. Stock Overview (U.S.: Nasdaq) | Barron’s

Complete Salarius Pharmaceuticals Inc. stock information by Barron’s. View real-time SLRX stock price and news, along with industry-best analysis.

Salarius Pharmaceuticals (Nasdaq:SLRX) – Stock Price, News …

SLRX Stock Overview. Salarius Pharmaceuticals, Inc., a clinical-stage biotechnology company, focuses on developing epigenetic-based cancer treatments.

SLRX – Salarius Pharmaceuticals Inc Forecast – CNNMoney.com

Stock Price Forecast … The 1 analysts offering 12-month price forecasts for Salarius Pharmaceuticals Inc have a median target of 125.00, with a high estimate of …

SLRX: Salarius Pharmaceuticals Inc Stock Price Quote

Stock analysis for Salarius Pharmaceuticals Inc (SLRX:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company …

SLRX – Salarius Pharmaceuticals, Inc. Stock Price and Quote

SLRX – Salarius Pharmaceuticals, Inc. – Stock screener for investors and traders, financial visualizations.